Kyunghee Burkitt, DO, PhD, is a medical oncologist at University Hospitals and is board certified in internal medicine.
Dr. Burkitt earned a BS in biochemistry from South Korea and a MS in cancer biology at Michigan State University in East Lansing, Mich. She went on to receive her PhD in cancer biology/toxicology at University of Michigan Cancer Center in Ann Arbor, Mich. After completing postdoctoral fellowships in hematology/oncology at University of Michigan and Michigan State University, she earned her medical degree at Michigan State University College of Osteopathic Medicine.
Dr. Burkitt completed her internal medicine residency training at Michigan State University, Sparrow Hospital in Lansing, Michigan, and a fellowship in medical oncology at the National Cancer Institute.
Dr. Burkitt is very active in research and has been published in numerous manuscripts. Research topics include epigenetic modification, DNA damage response pathways and introduction of novel therapies in clinical trials for head and neck cancer. Her clinical interests include improving response to chemotherapy and radiation therapy and immunotherapy in head and neck cancers.